InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Keutzer Timothy, Directeur du Développement. Insider active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 10 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €45k. Activity tracked since 26 August 2021. The latest transaction was filed on 6 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Keutzer Timothy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
18,652 股@ US$2.3682.9% 占其流量Common StockSEC:0001193125-26-043315:0
68,000 股0Common StockSEC:0001193125-26-038441:0
1,695 股@ US$1.9737.2% 占其流量Common StockSEC:0000950170-25-112659:0
266,139 股0Common StockSEC:0000950170-25-014866:0
2,213 股@ US$1.3555.3% 占其流量Common StockSEC:0000950170-24-101998:0
239,731 股0Common StockSEC:0000950170-24-011501:0
1,854 股@ US$1.2644.7% 占其流量Common StockSEC:0000950170-23-045450:0
265,957 股0Common StockSEC:0000899243-23-003948:0
38,014 股0Common StockSEC:0000899243-22-004589:0
24,067 股0Common StockSEC:0000899243-21-034499:0
10 条申报中的 10 条
About Keutzer Timothy
Keutzer Timothy is Directeur du Développement and Chief Operating Officer at Spero Therapeutics, Inc. The 10 filings on record, covering the sampled recent filings from 2021-08-30 to 2026-02-09, show 0 € in purchases and 45063 € in sales, with the stated transaction nature being Attribution.
